FREQUENTLY ASKED QUESTIONS

Glutathione therapy involves the administration of glutathione, a powerful antioxidant, to combat oxidative stress and support brain function.

- Reducing Symptoms and Slowing Disease Progression: Effective for conditions like Parkinson's disease, Alzheimer's disease, and multiple sclerosis. - Combating Oxidative Stress and Neuroinflammation: Helps counteract oxidative damage and neuroinflammation. - Increasing Glutathione Levels: More effective than oral supplements. - Potential Benefits for Other Neurological Conditions: May help reduce symptoms in fibromyalgia, peripheral artery disease, and autism.

Glutathione is administered intravenously (IV) to bypass the digestive system, ensuring better absorption and efficacy.

The regimen varies based on the condition being treated and individual patient needs. A healthcare provider will determine the appropriate dosage and frequency.

Each IV infusion session typically lasts between 30 minutes to an hour.

The duration allows for controlled administration of glutathione to ensure optimal absorption and effectiveness.

The process involves: 1. Consultation with a healthcare provider to assess suitability. 2. IV insertion by a trained professional. 3. Monitoring during the infusion for any adverse reactions.

Providers may ask about: 1.Allergies to glutathione or any components used in the infusion. 2.Existing medical conditions. 3.Current medications, especially those affecting glutathione levels.

Possible side effects include mild gastrointestinal discomfort, headache, or allergic reactions. These are typically rare and transient.

Patients often report improved energy levels and mental clarity. Some may experience mild discomfort at the injection site.

Yes, glutathione therapy is generally safe when administered under medical supervision. Proper patient selection and monitoring are essential to ensure safety.

IV Glutathione Therapy. Consultations for neurological health. Personalised treatment plans for various neurological conditions. REFERENCE BLOG: UNLOCKING THE POTENTIAL OF INTRAVENOUS GLUTATHIONE THERAPY FOR NEUROLOGICAL CONDITIONS

NAD therapy involves the administration of Nicotinamide adenine dinucleotide (NAD), a molecule essential for energy production, cellular health, and metabolism.

Improving Energy Levels: Increases activity of proteins linked to aging and DNA repair. Supporting Cognitive Function: Enhances memory and cognitive function. Reducing Inflammation: Possesses anti-inflammatory properties. Protecting Against Neurodegenerative Diseases: Potential benefits for Alzheimer's, Parkinson's, and other neurodegenerative diseases.

NAD is administered intravenously (IV) to bypass the digestive system, providing maximum bioavailability.

The regimen varies based on individual needs and the specific condition being treated. A healthcare provider will determine the appropriate dosage and frequency.

Infusion lasts from 1 to 4 hours depending on the dose required.

The duration allows for controlled administration of NAD to ensure optimal absorption and effectiveness.

The process involves: 1. Consultation with a healthcare provider to assess suitability. 2. IV insertion by a trained professional. 3. Monitoring during the infusion for any adverse reactions.

Providers may ask about: 1.Allergies to NAD or any components used in the infusion. 2.Existing medical conditions. 3.Current medications, especially those affecting NAD levels.

Possible side effects include flushing, headache, liver toxicity, and nausea. These are typically rare and transient.

Patients often report increased energy levels and improved mental clarity. Some may experience mild discomfort at the injection site.

Yes, NAD therapy is generally safe when administered under medical supervision. Proper patient selection and monitoring are essential to ensure safety.

- IV NAD Therapy - Consultations for neurological health - Personalised treatment plans for various neurological conditions